Treating Alzheimer's and Dementia With D-ribose
NCT02260141 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 3
Last updated 2020-05-08
Summary
To study the effectiveness of d-ribose in treating Alzheimer's and Dementia
Conditions
- Alzheimers
- Dementia
Interventions
- DIETARY_SUPPLEMENT
-
d-ribose
giving ribose in those with a diagnosis of Alzheimer's and/or dementia
Sponsors & Collaborators
-
Practitioners Alliance Network
lead OTHER
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2014-09-30
- Primary Completion
- 2017-10-31
- Completion
- 2017-10-31
Countries
- United States
Study Locations
More Related Trials
-
Bryostatin Treatment of Moderately Severe Alzheimer's Disease
NCT04538066 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Assess Safety and Target Engagement of E2814 in Participants With Mild to Moderate Cognitive Impairment Due to Dominantly Inherited Alzheimer's Disease
NCT04971733 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Study to Evaluate the Preliminary Safety, Efficacy, PK and PD of Bryostatin 1 in Patients With Alzheimer's Disease
NCT02221947 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Dose-Finding Study To Evaluate Safety, Tolerability, and Efficacy of E2609 in Participants With Mild Cognitive Impairment Due to Alzheimer's Disease (Prodromal Alzheimer's Disease) and Mild to Moderate Dementia Due to Alzheimer's Disease
NCT02322021 ·Status: TERMINATED ·Phase: PHASE2
-
Efficacy and Safety of MK-1942 as an Adjunct Therapy in Participants With Mild to Moderate Alzheimer's Disease Dementia (MK-1942-008)
NCT05602727 ·Status: TERMINATED ·Phase: PHASE2
-
Study of LY2886721 in Mild Cognitive Impairment Due to Alzheimer's Disease or Mild Alzheimer's Disease
NCT01561430 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
An Extension To The B1451006 Protocol To Evaluate The Safety and Efficacy of Dimebon In Subjects With Moderate-to-Severe Alzheimer's Disease
NCT01066546 ·Status: TERMINATED ·Phase: PHASE3
-
A Study of E2814 With Concurrent Lecanemab Treatment in Participants With Early Alzheimer's Disease
NCT06602258 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Study of Low Dose Whole Brain Irradiation in the Treatment of Alzheimer's Disease
NCT02359864 ·Status: TERMINATED ·Phase: NA
-
Effects of ONO-2506PO in Patients With Alzheimer's Disease
NCT00083421 ·Status: COMPLETED ·Phase: PHASE2
-
Dementias and Microbiota Composition: Is Possible to Revert the Dementia Symptoms Reverting the Microbiota Composition?
NCT05943925 ·Status: UNKNOWN
-
Lomecel-B Infusion Versus Placebo in Patients With Alzheimer's Disease
NCT02600130 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy and Safety of PRJ212 to Improve the Memory of Patients With Mild Severity Alzheimer's Disease
NCT02991235 ·Status: UNKNOWN ·Phase: NA
-
Brain Imaging Study Of Rosiglitazone Efficacy And Safety In Alzheimer's Disease
NCT00265148 ·Status: COMPLETED ·Phase: PHASE2
-
A Clinical Trial of AAV2-BDNF Gene Therapy in Early Alzheimer's Disease and Mild Cognitive Impairment
NCT05040217 ·Status: RECRUITING ·Phase: PHASE1
-
A Clinical Trial of a Vitamin/Nutriceutical Formulation for Alzheimer's Disease
NCT01320527 ·Status: COMPLETED ·Phase: PHASE2
-
Safety, Efficacy, Pharmacokinetics, and Pharmacodynamics Study of Bryostatin 1 in Patients With Alzheimer's Disease
NCT00606164 ·Status: UNKNOWN ·Phase: PHASE2
-
A Post Marketing Study in Participants With Early Alzheimer's Disease Treated With Lecanemab
NCT06322667 ·Status: RECRUITING
-
In Vivo Alzheimer Proteomics
NCT02263235 ·Status: TERMINATED ·Phase: NA
-
A Study of Lanabecestat (LY3314814) in Participants With Mild Alzheimer's Disease Dementia
NCT02783573 ·Status: TERMINATED ·Phase: PHASE3
-
Repurposing Riluzole for Cancer-Related Cognitive Impairment: A Pilot Trial
NCT06580002 ·Status: RECRUITING ·Phase: PHASE2
-
Improving Beta-2 Adrenergic Signaling in Alzheimer's Disease
NCT02500784 ·Status: WITHDRAWN ·Phase: PHASE2
-
An Extension To The B1451027 Protocol To Evaluate The Long Term Safety And Tolerability Of Dimebon In Patients With Alzheimer's Disease
NCT00939783 ·Status: TERMINATED ·Phase: PHASE3
-
Histidine Oral Supplementation as a Therapeutic Modality for Alzheimer's Disease
NCT06169826 ·Status: WITHDRAWN ·Phase: PHASE4
-
A Study to Evaluate the Safety and Efficacy of AstroStem in Treatment of Alzheimer's Disease
NCT03117738 ·Status: COMPLETED ·Phase: PHASE1/PHASE2